CME Information

This activity is jointly provided by University of Nebraska Medical Center and Bio Ascend.

Target Audience

The target audience for this activity is community and academic medical oncologists, hematologists, advance practitioners (NP/PA/PharmD), and other clinicians who treat patients with solid and hematologic cancers.

Learning Objectives

After participating in this activity, learners should be better able to:

  • Strive for and support other women in leadership positions in oncology
  • Foster team-based collaboration among women hematologists/oncologists, nurses, and other healthcare professionals
  • Acquire insights that help further personal and professional growth
  • Evaluate evidence regarding the impact of gender imbalance on patient care

Joint Accreditation Statement

Joint Accreditation Statement

In support of improving patient care, this activity has been
planned and implemented by the University of Nebraska Medical Center and Bio Ascend LLC. University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education (CME)

The University of Nebraska Medical Center designates this live activity for a maximum of 9 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants who complete the educational activity and evaluation will receive an accredited continuing education credit certificate.

As a jointly accredited provider, the University of Nebraska Medical Center (UNMC) ensures accuracy, balance, objectivity, independence, and scientific rigor in its educational activities and is committed to protecting learners from promotion, marketing, and commercial bias. All faculty, planner and others in a position to control continuing education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The accredited provider is responsible for mitigating all relevant financial relationships in accredited continuing education. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.

This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications. All materials are included with the permission of the faculty. The opinions expressed are those of the faculty and are not to be construed as those of UNMC or Bio Ascend.

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

All faculty and planning committee members have no conflicts to disclose with the exception of the following:


Planning Committee
The following planning committee members have nothing to disclose:
UNMC: Brenda Ram, CMP, CHCP
Bio Ascend: Patti Bunyasaranand, MS; Aimee Harwood; Allison Meier; Kraig Steubing

Request for Credit In order to obtain your CME/CE certificate, please follow the steps below within 30 days of the conclusion of the conference:

  1. Complete the program evaluation. A CME request form will pop up once you submit the evaluation
  2. Complete the CME request form and email to BRAM@UNMC.EDU
  3. Your certificate will be emailed to you within 30 days